These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [New antidepressive drugs].
    Author: Woggon B.
    Journal: Praxis (Bern 1994); 2000 Mar 23; 89(13):524-8. PubMed ID: 10776054.
    Abstract:
    Five of the available eight substance groups known as antidepressants has been developed during the last years: selective serotonin reuptake inhibitors (SSRI), selective serotonin and norepinephrine reuptake inhibitors (SNRI), serotonin antagonists, reversible selective inhibitors of monoaminooxidase A (RIMA) and St. Johns word. Two main ideas were important for their development: more specific biochemical effects and less side effects. This development is going further. During the next years at least three new substance groups with new biochemical effects will come on the market. The growing spectrum of antidepressants is important for avoiding therapy resistant depression.
    [Abstract] [Full Text] [Related] [New Search]